YH 1226
Latest Information Update: 19 Jun 2001
At a glance
- Originator Yuhan
- Class Antibacterials; Cephalosporins
- Mechanism of Action Cell wall inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Bacterial infections
Most Recent Events
- 19 Jun 2001 No-Development-Reported for Bacterial infections in South Korea (Unknown route)
- 12 Jan 1999 Preclinical development for Bacterial infections in South Korea (Unknown route)
- 16 Jun 1998 New profile